top of page
A once a day oral tablet, administered by the owner at home that works directly at the origin of the canine mast cell tumor to lead to long term tumor control.
Mast cell tumors are one of the leading cancers in canines.
Kinavet-CA1®
Kinavet-CA1® is labeled for the treatment of nonresectable Grade II and Grade III cutaneous mast cell tumors in dogs that have not previously received radiotherapy and/or chemotherapy except corticosteroids.
For a more detailed description of the conditional approval, please visit this FAQ made by the FDA.
bottom of page